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A 54-year-old female patient presented with nonspecific abdominal pain 
that had been gradually worsening for approximately two months. She denied 
significant weight loss. Physical examination showed a distended abdomen and 
a painful palpable mass in the epigastrium. Laboratory studies showed a white 
blood cell count of 27,000 cells/mL, a C-reactive protein level of 199 mg/dL, 
a CA 19-9 level of 656 U/mL, and a hemoglobin count of 10.9 g/dL, as well 
as normal values of gamma-glutamyl transpeptidase, total bilirubin, alkaline 
phosphatase, hepatic transaminases, and amylase.
A computed tomography (CT) scan of the abdomen identified a large, 
heterogeneous, expansive lesion with a geometric center in the pancreatic 
head and body, measuring 6.4 x 5.1 x 3.2 cm, with irregular margins and 
heterogeneous enhancement with hypodense central areas suggestive of 
necrosis/liquefaction. This lesion showed signs of vascular involvement, 
especially portal vein invasion, and involvement of the branches of the 
celiac trunk and mesenteric vessels, contraindicating surgical treatment 
(Figures 1A and 1B). The patient underwent a new CT scanning two 
months later, which demonstrated a significant increase of the pancreatic 
lesion, lymph node enlargement, and the development of hepatic lesions 
compatible with metastases. The compression and invasion of the main bile 
duct was also observed, determining the dilatation of intra- and extrahepatic 
bile ducts, demonstrated by percutaneous transhepatic cholangiography 
(Figure 2A, B, and C). A biopsy of the lesion showed an undifferentiated, 
high-grade pleomorphic malignancy with necrosis. The immunohistochemical 
profile confirmed the diagnosis of pancreatic sarcoma with positivity for the 
cell-surface vimentin (CSV) marker (Figure 3A and B). The patient died after 
a few weeks due to significant clinical worsening.
Primary pancreatic sarcomas are extremely rare entities, accounting for less 
than 0.1% of all pancreatic neoplasms1. They originate from the mesenchymal 
tissue of pancreatic support, and the leiomyosarcoma subtype is the most 
frequently reported2. This neoplasia usually presents poor prognosis due to 
late diagnosis and accelerated growth relative to other pancreatic neoplasia1,3. 
The pancreatic head is the most commonly involved site, followed by the tail 
and body, and it occurs more frequently in younger individuals3. Clinically, 
patients may present with weight loss, palpable abdominal mass, epigastric 
pain, nausea and vomiting, similar to other pancreatic diseases, thus being 
unspecific to sarcomas1-3. On CT scanning, the findings include a bulky, 
heterogeneous mass and, with peripheral enhancement after contrast injection, 
pseudocystic masses are also described.
CSV is an exclusive marker of sarcoma regardless of its tissue origin4. 
The prognosis is influenced by the patient’s age, tumor size, the presence 
of tumor necrosis, and vascular invasion. The curative treatment is surgical 
– extensive surgical resection should be advocated, even when morphologic 
results show a low-grade lesion2. The tumor is likely to metastasize to the liver 
but not to regional lymph nodes. The role of chemotherapy and radiotherapy 
in pancreatic sarcoma has not been well studied5.
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Figure 1: An initial computed tomography scan in axial (A) and coronal (B) planes shows a heterogeneous mass centered 
within the pancreatic body (arrows) extending to the pancreatic head with signs of vascular involvement, especially the 
mesenteric vessels and branches of the celiac trunk.
Figure 2: A CT scan in the axial (A) and coronal (B) planes shows an important increase of the pancreatic heterogeneous 
mass (arrows), as well as invasion of adjacent structures. Cholangiography (C) shows dilatation of the intrahepatic bile 
ducts and abrupt decrease in the caliber of the common bile duct at the level of the hepatic hilum.
Figure 3: A: Undifferentiated, pleomorphic, high-grade malignant neoplasm with necrosis. B: Immunohistochemical profile 
compatible with undifferentiated, pleomorphic, high-grade sarcoma.
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